Cover Image
Market Research Report
Product code 
1051542

Global Drug-Device Combination Products Market Report, History and Forecast 2016-2027

Published: | QYResearch | 147 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Drug-Device Combination Products Market Report, History and Forecast 2016-2027
Published: January 22, 2022
QYResearch
Content info: 147 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Market Analysis and Insights:

The research report studies the Drug-Device Combination Products market using different methodologies and analyses to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.

The global Drug-Device Combination Products market size is projected to reach US$ 117202 million by 2027, from US$ 76220 million in 2020, at a CAGR of 6.24% during 2021-2027.

Scope and Segment:

The global Drug-Device Combination Products market is segmented by company, region (country), by Type, and By Application. Players, stakeholders, and other participants in the global Drug-Device Combination Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and By Application for the period 2016-2027.

By Company

  • GSK
  • Novo Nordisk
  • Eli Lilly
  • AstraZeneca
  • Sanofi
  • Boston Scientific
  • Abbott
  • Boehringer Ingelheim
  • Medtronic
  • Mylan
  • 3M
  • Hisamitsu
  • Smith & Nephew
  • Molnlycke
  • Teleflex
  • BD
  • Lepu Medical
  • MicroPort
  • Terumo
  • B. Braun
  • Antares Pharma

Segment by Type

  • Drug-Coated Device
  • Prefilled Drug Delivery Systems
  • Nebulizer & Inhaler
  • Transdermal Delivery System
  • Other

Segment by Application

  • Hospital & Clinic
  • Retail Pharmacies
  • Other

By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • South America
    • Brazil
  • Middle East & Africa
    • Middle East
    • Africa

TABLE OF CONTENTS

1 MARKET OVERVIEW OF DRUG-DEVICE COMBINATION PRODUCTS

  • 1.1 Drug-Device Combination Products Market Overview
    • 1.1.1 Drug-Device Combination Products Product Scope
    • 1.1.2 Drug-Device Combination Products Market Status and Outlook
  • 1.2 Drug-Device Combination Products Market Overview by Type
    • 1.2.1 Drug-Coated Device
    • 1.2.2 Prefilled Drug Delivery Systems
    • 1.2.3 Nebulizer & Inhaler
    • 1.2.4 Transdermal Delivery System
  • 1.3 Global Drug-Device Combination Products Market Size by Type
    • 1.3.1 Global Drug-Device Combination Products Market Size Overview by Type (2016-2027)
    • 1.3.2 Global Drug-Device Combination Products Historic Market Size Review by Type (2016-2021)
    • 1.3.3 Global Drug-Device Combination Products Forecasted Market Size by Type (2022-2027)
  • 1.4 Key Regions Market Size Segment by Type
    • 1.4.1 North America Drug-Device Combination Products Revenue Breakdown by Type (2016-2021)
    • 1.4.2 Europe Drug-Device Combination Products Revenue Breakdown by Type (2016-2021)
    • 1.4.3 Asia-Pacific Drug-Device Combination Products Revenue Breakdown by Type (2016-2021)
    • 1.4.4 South America Drug-Device Combination Products Revenue Breakdown by Type (2016-2021)
    • 1.4.5 Middle East and Africa Drug-Device Combination Products Revenue Breakdown by Type (2016-2021)

2 DRUG-DEVICE COMBINATION PRODUCTS MARKET COMPETITION BY COMPANY

  • 2.1 Global Drug-Device Combination Products Market Size by Players (2019-2021)
  • 2.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2020)
  • 2.3 Founded Date of Key Drug-Device Combination Products Players
  • 2.4 Global Top Players Drug-Device Combination Products Headquarters and Area Served
  • 2.5 Key Players Drug-Device Combination Products Product Solution and Service
  • 2.6 Competitive Status
    • 2.6.1 Drug-Device Combination Products Market Concentration Rate
    • 2.6.2 Mergers & Acquisitions, Expansion Plans

3 DRUG-DEVICE COMBINATION PRODUCTS STATUS AND OUTLOOK BY REGION

  • 3.1 Global Drug-Device Combination Products Market Size Overview by Region 2016 VS 2021 VS 2027
  • 3.2 Global Drug-Device Combination Products Market Size by Region (2016-2027)
  • 3.3 Global Drug-Device Combination Products Historic Market Size by Region (2016-2021)
  • 3.4 Global Drug-Device Combination Products Market Size Forecast by Region (2022-2027)

4 DRUG-DEVICE COMBINATION PRODUCTS MARKET OVERVIEW BY APPLICATION

  • 4.1 Drug-Device Combination Products Market Segment by Application
    • 4.1.1 Hospital & Clinic
    • 4.1.2 Retail Pharmacies
  • 4.2 Global Drug-Device Combination Products Market Size by Application
    • 4.2.1 Global Drug-Device Combination Products Market Size Overview by Application (2016-2027)
    • 4.2.2 Global Drug-Device Combination Products Historic Market Size by Application (2016-2021)
    • 4.2.3 Global Drug-Device Combination Products Forecasted Market Size by Application (2022-2027)
  • 4.3 Key Regions Market Size Segment by Application
    • 4.3.1 North America Drug-Device Combination Products Revenue Breakdown by Application (2016-2021)
    • 4.3.2 Europe Drug-Device Combination Products Revenue Breakdown by Application (2016-2021)
    • 4.3.3 Asia-Pacific Drug-Device Combination Products Revenue Breakdown by Application (2016-2021)
    • 4.3.4 South America Drug-Device Combination Products Revenue Breakdown by Application (2016-2021)
    • 4.3.5 Middle East and Africa Drug-Device Combination Products Revenue Breakdown by Application (2016-2021)

5 NORTH AMERICA

  • 5.1 North America Drug-Device Combination Products Market Size by Country (2016-2027)
  • 5.2 United States
  • 5.3 Canada
  • 5.4 Mexico

6 EUROPE

  • 6.1 Europe Drug-Device Combination Products Market Size by Country (2016-2027)
  • 6.2 Germany
  • 6.3 France
  • 6.4 U.K.
  • 6.5 Italy
  • 6.6 Russia
  • 6.7 Rest of Europe

7 ASIA-PACIFIC

  • 7.1 Asia-Pacific Drug-Device Combination Products Market Size by Region (2016-2027)
  • 7.2 China
  • 7.3 Japan
  • 7.4 South Korea
  • 7.5 Southeast Asia
  • 7.6 India
  • 7.7 Australia
  • 7.8 Rest of Asia-Pacific

8 SOUTH AMERICA

  • 8.1 South America Drug-Device Combination Products Market Size by Country (2016-2027)
  • 8.2 Brazil
  • 8.3 Rest of South America

9 MIDDLE EAST & AFRICA

  • 9.1 Middle East & Africa Drug-Device Combination Products Market Size by Country
  • 9.2 Middle East
  • 9.3 Africa

10 COMPANY PROFILES AND KEY FIGURES IN DRUG-DEVICE COMBINATION PRODUCTS BUSINESS

  • 10.1 GSK
    • 10.1.1 GSK Corporation Information
    • 10.1.2 GSK Introduction and Business Overview
    • 10.1.3 GSK Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.1.4 GSK Drug-Device Combination Products Offered
    • 10.1.5 GSK Recent Development
  • 10.2 Novo Nordisk
    • 10.2.1 Novo Nordisk Corporation Information
    • 10.2.2 Novo Nordisk Introduction and Business Overview
    • 10.2.3 Novo Nordisk Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.2.4 Novo Nordisk Drug-Device Combination Products Offered
    • 10.2.5 Novo Nordisk Recent Development
  • 10.3 Eli Lilly
    • 10.3.1 Eli Lilly Corporation Information
    • 10.3.2 Eli Lilly Introduction and Business Overview
    • 10.3.3 Eli Lilly Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.3.4 Eli Lilly Drug-Device Combination Products Offered
    • 10.3.5 Eli Lilly Recent Development
  • 10.4 AstraZeneca
    • 10.4.1 AstraZeneca Corporation Information
    • 10.4.2 AstraZeneca Introduction and Business Overview
    • 10.4.3 AstraZeneca Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.4.4 AstraZeneca Drug-Device Combination Products Offered
    • 10.4.5 AstraZeneca Recent Development
  • 10.5 Sanofi
    • 10.5.1 Sanofi Corporation Information
    • 10.5.2 Sanofi Introduction and Business Overview
    • 10.5.3 Sanofi Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.5.4 Sanofi Drug-Device Combination Products Offered
    • 10.5.5 Sanofi Recent Development
  • 10.6 Boston Scientific
    • 10.6.1 Boston Scientific Corporation Information
    • 10.6.2 Boston Scientific Introduction and Business Overview
    • 10.6.3 Boston Scientific Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.6.4 Boston Scientific Drug-Device Combination Products Offered
    • 10.6.5 Boston Scientific Recent Development
  • 10.7 Abbott
    • 10.7.1 Abbott Corporation Information
    • 10.7.2 Abbott Introduction and Business Overview
    • 10.7.3 Abbott Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.7.4 Abbott Drug-Device Combination Products Offered
  • 10.8 Boehringer Ingelheim
    • 10.8.1 Boehringer Ingelheim Corporation Information
    • 10.8.2 Boehringer Ingelheim Introduction and Business Overview
    • 10.8.3 Boehringer Ingelheim Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.8.4 Boehringer Ingelheim Drug-Device Combination Products Offered
    • 10.8.5 Boehringer Ingelheim Recent Development
  • 10.9 Medtronic
    • 10.9.1 Medtronic Corporation Information
    • 10.9.2 Medtronic Introduction and Business Overview
    • 10.9.3 Medtronic Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.9.4 Medtronic Drug-Device Combination Products Offered
    • 10.9.5 Medtronic Recent Development
  • 10.10 Mylan
    • 10.10.1 Mylan Corporation Information
    • 10.10.2 Mylan Introduction and Business Overview
    • 10.10.3 Mylan Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.10.4 Mylan Drug-Device Combination Products Offered
    • 10.10.5 Mylan Recent Development
  • 10.11 3M
    • 10.11.1 3M Corporation Information
    • 10.11.2 3M Introduction and Business Overview
    • 10.11.3 3M Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.11.4 3M Drug-Device Combination Products Offered
  • 10.12 Hisamitsu
    • 10.12.1 Hisamitsu Corporation Information
    • 10.12.2 Hisamitsu Introduction and Business Overview
    • 10.12.3 Hisamitsu Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.12.4 Hisamitsu Drug-Device Combination Products Offered
  • 10.13 Smith & Nephew
    • 10.13.1 Smith & Nephew Corporation Information
    • 10.13.2 Smith & Nephew Introduction and Business Overview
    • 10.13.3 Smith & Nephew Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.13.4 Smith & Nephew Drug-Device Combination Products Offered
    • 10.13.5 Smith & Nephew Recent Development
  • 10.14 Molnlycke
    • 10.14.1 Molnlycke Corporation Information
    • 10.14.2 Molnlycke Introduction and Business Overview
    • 10.14.3 Molnlycke Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.14.4 Molnlycke Drug-Device Combination Products Offered
  • 10.15 Teleflex
    • 10.15.1 Teleflex Corporation Information
    • 10.15.2 Teleflex Introduction and Business Overview
    • 10.15.3 Teleflex Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.15.4 Teleflex Drug-Device Combination Products Offered
    • 10.15.5 Teleflex Recent Development
  • 10.16 BD
    • 10.16.1 BD Corporation Information
    • 10.16.2 BD Introduction and Business Overview
    • 10.16.3 BD Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.16.4 BD Drug-Device Combination Products Offered
  • 10.17 Lepu Medical
    • 10.17.1 Lepu Medical Corporation Information
    • 10.17.2 Lepu Medical Introduction and Business Overview
    • 10.17.3 Lepu Medical Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.17.4 Lepu Medical Drug-Device Combination Products Offered
  • 10.18 MicroPort
    • 10.18.1 MicroPort Corporation Information
    • 10.18.2 MicroPort Introduction and Business Overview
    • 10.18.3 MicroPort Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.18.4 MicroPort Drug-Device Combination Products Offered
  • 10.19 Terumo
    • 10.19.1 Terumo Corporation Information
    • 10.19.2 Terumo Introduction and Business Overview
    • 10.19.3 Terumo Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.19.4 Terumo Drug-Device Combination Products Offered
  • 10.20 B. Braun
    • 10.20.1 B. Braun Corporation Information
    • 10.20.2 B. Braun Introduction and Business Overview
    • 10.20.3 B. Braun Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.20.4 B. Braun Drug-Device Combination Products Offered
  • 10.21 Antares Pharma
    • 10.21.1 Antares Pharma Corporation Information
    • 10.21.2 Antares Pharma Introduction and Business Overview
    • 10.21.3 Antares Pharma Drug-Device Combination Products Revenue and Gross Margin (2019-2021)
    • 10.21.4 Antares Pharma Drug-Device Combination Products Offered

11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

  • 11.1 Drug-Device Combination Products Key Raw Materials
    • 11.1.1 Key Raw Materials
    • 11.1.2 Key Raw Materials Market Concentration Rate
    • 11.1.3 Raw Materials Key Suppliers
  • 11.2 Manufacturing Cost Structure
    • 11.2.1 Raw Materials
    • 11.2.2 Labor Cost
    • 11.2.3 Manufacturing Expenses
  • 11.3 Drug-Device Combination Products Industrial Chain Analysis
  • 11.4 Drug-Device Combination Products Market Dynamics
    • 11.4.1 Drug-Device Combination Products Industry Trends
    • 11.4.2 Drug-Device Combination Products Market Drivers
    • 11.4.3 Drug-Device Combination Products Market Challenges
    • 11.4.4 Drug-Device Combination Products Market Restraints

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS

  • 12.1 Sales Channel
  • 12.2 Drug-Device Combination Products Distributors
  • 12.3 Drug-Device Combination Products Downstream Customers

13 RESEARCH FINDING/CONCLUSION

14 METHODOLOGY AND DATA SOURCE

  • 14.1 Methodology/Research Approach
    • 14.1.1 Research Programs/Design
    • 14.1.2 Market Size Estimation
    • 14.1.3 Market Breakdown and Data Triangulation
  • 14.2 Data Source
    • 14.2.1 Secondary Sources
    • 14.2.2 Primary Sources
  • 14.3 Disclaimer
  • 14.4 Author List 130

LIST OF TABLES

  • Table 1. Major Company of Drug-Coated Device
  • Table 2. Major Company of Prefilled Drug Delivery Systems
  • Table 3. Major Company of Nebulizer & Inhaler
  • Table 4. Major Company of Transdermal Delivery System
  • Table 5. Global Drug-Device Combination Products Revenue by Type: 2016 VS 2021 VS 2027 (US$ Million)
  • Table 6. Global Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million)
  • Table 7. Global Drug-Device Combination Products Revenue Market Share by Type (2016-2021)
  • Table 8. Global Drug-Device Combination Products Revenue by Type (2022-2027) & (US$ Million)
  • Table 9. Global Drug-Device Combination Products Revenue Market Share by Type (2022-2027)
  • Table 10. North America Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million)
  • Table 11. Europe Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million)
  • Table 12. Asia-Pacific Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million)
  • Table 13. South America Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million)
  • Table 14. Middle East and Africa Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million)
  • Table 15. Global Drug-Device Combination Products Revenue (US$ Million) by Players (2019-2021)
  • Table 16. Global Drug-Device Combination Products Revenue Market Share by Players (2019-2021)
  • Table 17. Global Top Players Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2020)
  • Table 18. Founded Date of Key Drug-Device Combination Products Players
  • Table 19. Global Drug-Device Combination Products Top Players Headquarters and Area Served
  • Table 20. Drug-Device Combination Products Product Solution and Service
  • Table 21. Global Drug-Device Combination Products Players Market Concentration Ratio (CR5 and HHI)
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Market Drug-Device Combination Products Market Size (US$ Million) Comparison by Region: 2016 VS 2021 VS 2027
  • Table 24. Global Drug-Device Combination Products Market Size by Region (2016-2021) & (US$ Million)
  • Table 25. Global Drug-Device Combination Products Market Size Share by Region (2016-2021)
  • Table 26. Global Drug-Device Combination Products Forecasted Market Size by Region (2022-2027) & (US$ Million)
  • Table 27. Global Drug-Device Combination Products Forecasted Market Size Share by Region (2022-2027)
  • Table 28. Global Drug-Device Combination Products Market Size (US$ Million) By Application: 2016 VS 2021 VS 2027
  • Table 29. Global Drug-Device Combination Products Market Size by Application (2016-2021) & (US$ Million)
  • Table 30. Global Drug-Device Combination Products Revenue Market Share by Application (2016-2021)
  • Table 31. Global Drug-Device Combination Products Forecasted Market Size by Application (2022-2027) & (US$ Million)
  • Table 32. Global Drug-Device Combination Products Revenue Market Share by Application (2022-2027)
  • Table 33. North America Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million)
  • Table 34. Europe Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million)
  • Table 35. Asia-Pacific Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million)
  • Table 36. South America Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million)
  • Table 37. South America Drug-Device Combination Products Revenue Market Share by Application (2016-2021)
  • Table 38. Middle East and Africa Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million)
  • Table 39. North America Drug-Device Combination Products Market Size by Country (2016-2021) & (US$ Million)
  • Table 40. North America Drug-Device Combination Products Market Size by Country (2022-2027) & (US$ Million)
  • Table 41. Europe Drug-Device Combination Products Market Size by Country (2016-2021) & (US$ Million)
  • Table 42. Europe Drug-Device Combination Products Market Size by Country (2022-2027) & (US$ Million)
  • Table 43. Europe Drug-Device Combination Products Market Share by Country (2016-2021)
  • Table 44. Europe Drug-Device Combination Products Market Share by Country (2022-2027)
  • Table 45. Asia-Pacific Drug-Device Combination Products Market Size by Region (2016-2021) & (US$ Million)
  • Table 46. Asia-Pacific Drug-Device Combination Products Market Size by Region (2022-2027) & (US$ Million)
  • Table 47. Asia-Pacific Drug-Device Combination Products Market Share by Region (2016-2021)
  • Table 48. Asia-Pacific Drug-Device Combination Products Market Share by Region (2022-2027)
  • Table 49. South America Drug-Device Combination Products Market Size by Country (2016-2021) & (US$ Million)
  • Table 50. South America Drug-Device Combination Products Market Size by Country (2022-2027) & (US$ Million)
  • Table 51. Middle East & Africa Drug-Device Combination Products Market Size by Country (2016-2021) & (US$ Million)
  • Table 52. Middle East & Africa Drug-Device Combination Products Market Size by Country (2022-2027) & (US$ Million)
  • Table 53. GSK Corporation Information
  • Table 54. GSK Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 55. GSK Drug-Device Combination Products Product
  • Table 56. GSK Recent Development
  • Table 57. Novo Nordisk Corporation Information
  • Table 58. Novo Nordisk Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 59. Novo Nordisk Drug-Device Combination Products Product
  • Table 60. Novo Nordisk Recent Development
  • Table 61. Eli Lilly Corporation Information
  • Table 62. Eli Lilly Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 63. Eli Lilly Drug-Device Combination Products Product
  • Table 64. Eli Lilly Recent Development
  • Table 65. AstraZeneca Corporation Information
  • Table 66. AstraZeneca Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 67. AstraZeneca Drug-Device Combination Products Product
  • Table 68. AstraZeneca Recent Development
  • Table 69. Sanofi Corporation Information
  • Table 70. Sanofi Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 71. Sanofi Drug-Device Combination Products Product
  • Table 72. Sanofi Recent Development
  • Table 73. Boston Scientific Corporation Information
  • Table 74. Boston Scientific Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 75. Boston Scientific Drug-Device Combination Products Product
  • Table 76. Boston Scientific Recent Development
  • Table 77. Abbott Corporation Information
  • Table 78. Abbott Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 79. Abbott Drug-Device Combination Products Product
  • Table 80. Boehringer Ingelheim Corporation Information
  • Table 81. Boehringer Ingelheim Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 82. Boehringer Ingelheim Drug-Device Combination Products Product
  • Table 83. Boehringer Ingelheim Recent Development
  • Table 84. Medtronic Corporation Information
  • Table 85. Medtronic Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 86. Medtronic Drug-Device Combination Products Product
  • Table 87. Medtronic Recent Development
  • Table 88. Mylan Corporation Information
  • Table 89. Mylan Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 90. Mylan Drug-Device Combination Products Product
  • Table 91. Mylan Recent Development
  • Table 92. 3M Corporation Information
  • Table 93. 3M Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 94. 3M Drug-Device Combination Products Product
  • Table 95. Hisamitsu Corporation Information
  • Table 96. Hisamitsu Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 97. Hisamitsu Drug-Device Combination Products Product
  • Table 98. Smith & Nephew Corporation Information
  • Table 99. Smith & Nephew Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 100. Smith & Nephew Drug-Device Combination Products Product
  • Table 101. Smith & Nephew Recent Development
  • Table 102. Molnlycke Corporation Information
  • Table 103. Molnlycke Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 104. Molnlycke Drug-Device Combination Products Product
  • Table 105. Teleflex Corporation Information
  • Table 106. Teleflex Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 107. Teleflex Drug-Device Combination Products Product
  • Table 108. Teleflex Recent Development
  • Table 109. BD Corporation Information
  • Table 110. BD Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 111. BD Drug-Device Combination Products Product
  • Table 112. Lepu Medical Corporation Information
  • Table 113. Lepu Medical Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 114. Lepu Medical Drug-Device Combination Products Product
  • Table 115. MicroPort Corporation Information
  • Table 116. MicroPort Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 117. MicroPort Drug-Device Combination Products Product
  • Table 118. Terumo Corporation Information
  • Table 119. Terumo Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 120. Terumo Drug-Device Combination Products Product
  • Table 121. B. Braun Corporation Information
  • Table 122. B. Braun Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 123. B. Braun Drug-Device Combination Products Product
  • Table 124. Antares Pharma Corporation Information
  • Table 125. Antares Pharma Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021)
  • Table 126. Antares Pharma Drug-Device Combination Products Product
  • Table 127. Raw Materials Key Suppliers Lists
  • Table 128. Drug-Device Combination Products Market Trends
  • Table 129. Drug-Device Combination Products Market Drivers
  • Table 130. Drug-Device Combination Products Market Challenges
  • Table 131. Drug-Device Combination Products Market Restraints
  • Table 132. Drug-Device Combination Products Distributors List
  • Table 133. Drug-Device Combination Products Downstream Customers
  • Table 134. Research Programs/Design for This Report
  • Table 135. Key Data Information from Secondary Sources
  • Table 136. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Drug-Device Combination Products Product Picture
  • Figure 2. Global Drug-Device Combination Products Market Size Year-over-Year 2016-2027 & (US$ Million)
  • Figure 3. Global Drug-Device Combination Products Market Size, (US$ Million), 2016 VS 2021 VS 2027
  • Figure 4. Product Picture of Drug-Coated Device
  • Figure 5. Drug-Coated Device Market Size (US$ Million) & YoY Growth (2016-2027)
  • Figure 6. Product Picture of Prefilled Drug Delivery Systems
  • Figure 7. Prefilled Drug Delivery Systems Market Size (US$ Million) & YoY Growth (2016-2027)
  • Figure 8. Product Picture of Nebulizer & Inhaler
  • Figure 9. Nebulizer & Inhaler Market Size (US$ Million) & YoY Growth (2016-2027)
  • Figure 10. Product Picture of Transdermal Delivery System
  • Figure 11. Transdermal Delivery System Market Size (US$ Million) & YoY Growth (2016-2027)
  • Figure 12. Global Drug-Device Combination Products Revenue by Type (2016-2027) & (US$ Million)
  • Figure 13. Global Drug-Device Combination Products Revenue Market Share by Type (2016-2021)
  • Figure 14. Global Drug-Device Combination Products Revenue Market Share by Type (2022-2027)
  • Figure 15. North America Drug-Device Combination Products Revenue Market Share by Type in 2020
  • Figure 16. Europe Drug-Device Combination Products Revenue Market Share by Type in 2020
  • Figure 17. Asia-Pacific Drug-Device Combination Products Revenue Market Share by Type in 2020
  • Figure 18. South America Drug-Device Combination Products Revenue Market Share by Type in 2020
  • Figure 19. Middle East and Africa Drug-Device Combination Products Revenue Market Share by Type in 2020
  • Figure 20. Global Top 5 Players Drug-Device Combination Products Market Share in 2020
  • Figure 21. Global Drug-Device Combination Products Market Share by Region: 2021
  • Figure 22. Global Drug-Device Combination Products Market Share by Region: 2027
  • Figure 23. Global Drug-Device Combination Products Forecasted Market Size Share by Region (2022-2027)
  • Figure 24. Product Picture of Hospital & Clinic
  • Figure 25. Global Hospital & Clinic Revenue YoY Growth (2016-2027) & (Million USD)
  • Figure 26. Product Picture of Retail Pharmacies
  • Figure 27. Global Retail Pharmacies Revenue YoY Growth (2016-2027) & (Million USD)
  • Figure 28. Global Drug-Device Combination Products Market Size Share by Application in 2021
  • Figure 29. Global Drug-Device Combination Products Market Size Share by Application in 2027
  • Figure 30. North America Drug-Device Combination Products Revenue Market Share by Application 2016-2021
  • Figure 31. Europe Drug-Device Combination Products Revenue Market Share by Application (2016-2021)
  • Figure 32. Asia-Pacific Drug-Device Combination Products Revenue Market Share by Application (2016-2021)
  • Figure 33. Middle East and Africa Drug-Device Combination Products Revenue Market Share by Application (2016-2021)
  • Figure 34. North America Drug-Device Combination Products Market Share by Country (2016-2027)
  • Figure 35. United States Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 36. Canada Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 37. Mexico Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 38. Germany Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 39. France Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 40. U.K. Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 41. Italy Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 42. Russia Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 43. Rest of Europe Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 44. Asia-Pacific Drug-Device Combination Products Market Share by Region (2016-2027)
  • Figure 45. China Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 46. Japan Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 47. South Korea Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 48. Southeast Asia Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 49. India Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 50. Australia Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 51. Rest of Asia-Pacific Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 52. South America Drug-Device Combination Products Market Share by Country (2016-2027)
  • Figure 53. Brazil Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 54. Rest of South America Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 55. Middle East & Africa Drug-Device Combination Products Market Share by Country (2020)
  • Figure 56. Middle East Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 57. Africa Drug-Device Combination Products Market Size (2016-2027) & (US$ Million)
  • Figure 58. Key Raw Materials Market Concentration Rate
  • Figure 59. Drug-Device Combination Products Industrial Chain Analysis
  • Figure 60. Channels of Distribution
  • Figure 61. Distributors Profiles
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation